Gufic Biosciences Limited (BOM:509079)
India flag India · Delayed Price · Currency is INR
276.85
-2.40 (-0.86%)
At close: Mar 9, 2026

Gufic Biosciences Company Description

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America.

The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals.

It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments.

In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products.

Further, it engages in contract and bulk drug manufacturing business. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.

Gufic Biosciences Limited
Country India
Founded 1970
Industry Pharmaceutical Preparations
Employees 1,484
CEO Pranav Choksi

Contact Details

Address:
S.M. House
Mumbai, Maharashtra 400057
India
Phone 91 22 6726 1000
Website gufic.com

Stock Details

Ticker Symbol 509079
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Pranav Choksi Chief Executive Officer
Devkinandan Roonghta Chief Financial Officer
Nagesh Yarrabathina Chief Operating Officer
Avik Das Head of Investor Relations